Al-Ola A Abdallah, Director of Plasma Cell Disorder Program at the University of Kansas Medical Center, shared a post on X:
“At National ICE-T conference, Barry Paul, MD spotlighted cilta-cel, anito-cel and arlo-cel as top CAR T-cell therapies in multiple myeloma – offering deep remissions, one-and-done infusions, and lower toxicity.”
More posts featuring Al-Ola Abdallah.